skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

4757

Neuropsychiatric Disease and Treatment

(1,264,220) Views

Editor in Chief Dr Roger M Pinder

1176-6328

Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran
Naghmeh Mokhber, Carol J Lane, Mohamad R Azarpazhooh, Elham Salari, Reza Fayazi, et al

The classification of chronic daily headache in French children and adolescents: A comparison between the second edition of the International Classification of Headache Disorders and Silberstein-Lipton criteria
Jean-Christophe Cuvellier, Frédéric Couttenier, Stéphane Auvin, Louis Vallée

The relationship between early life stress and microstructural integrity of the corpus callosum in a non-clinical population
Robert Paul, Lorrie Henry, Stuart M Grieve, Thomas J Guilmette, Raymond Niaura, et al

Treatment of adult ADHD: Is current knowledge useful to clinicians?
Terje Torgersen, Bjørn Gjervan, Kirsten Rasmussen

Resting and reactive frontal brain electrical activity (EEG) among a non-clinical sample of socially anxious adults: Does concurrent depressive mood matter?
Elliott A Beaton, Louis A Schmidt, Andrea R Ashbaugh, Diane L Santesso, Martin M Antony, Randi E McCabe

Risperidone treatment for ADHD in children and adolescents with bipolar disorder
Joseph Biederman, Paul Hammerness, Robert Doyle, Gagan Joshi, Megan Aleardi, Eric Mick

Relationship between obesity and antipsychotic drug use in the adult population: A longitudinal, retrospective claim database study in Primary Care settings
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Javier Rejas-Gutiérrez, Milagrosa Blanca-Tamayo

Neurosteroids block the increase in intracellular calcium level induced by Alzheimer’s β-amyloid protein in long-term cultured rat hippocampal neurons
Midori Kato-Negishi, Masahiro Kawahara

Editorial Foreword: Drugs for Parkinson’s disease: Levodopa is still the gold standard || FREE PAPER ||
Roger M Pinder

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
Angelo Antonini, Giovanni Abbruzzese, Paolo Barone, Ubaldo Bonuccelli, Leonardo Lopiano, et al

Rasagiline in treatment of Parkinson’s disease
Lakshmi Nayak, Claire Henchcliffe

Quetiapine monotherapy for bipolar depression
Michael E Thase


Monotherapy for partial epilepsy: focus on levetiracetam
Antonio Gambardella, Angelo Labate, Eleonora Colosimo, Roberta Ambrosio, Aldo Quattrone

Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
David J Brooks

Review of frovatriptan in the treatment of migraine
Leslie Kelman

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
Jeffrey R Bishop, Mani N Pavuluri

A review of ramelteon in the treatment of sleep disorders
David N Neubauer

Depression in Parkinson’s disease: Health risks, etiology, and treatment options
Pasquale G Frisina, Joan C Borod, Nancy S Foldi, Harriet R Tenenbaum

Pharmacological management of panic disorder
Carlo Marchesi

Treatment of adults with attention-deficit/hyperactivity disorder
Dusan Kolar, Amanda Keller, Maria Golfinopoulos, Lucy Cumyn, Cassidy Syer, Lily Hechtman

Social anxiety disorder: A review of environmental risk factors
Christina A Brook, Louis A Schmidt

Epidemiology and treatment of post-stroke depression
Stefano Paolucci

Gait analysis in demented subjects: Interests and perspectives
Olivier Beauchet, Gilles Allali, Gilles Berrut, Caroline Hommet, Véronique Dubost, Frédéric Assal

Adenylyl cyclase-cyclicAMP signaling in mood disorders: Role of the crucial phosphorylating enzyme protein kinase A
Yogesh Dwivedi, Ghanshyam N Pandey

Functional MRI evidence for language plasticity in adult epileptic patients: Preliminary results
Emilie Cousin, Monica Baciu, Cédric Pichat1, Philippe Kahane, Jean-François Le Bas

Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
Maurizio Pompili, Marco Innamorati, Michele Raja, Ilaria Falcone, Giuseppe Ducci, et al

Prevalence of eating disorders and eating attacks in narcolepsy
Norbert Dahmen, Julia Becht, Alice Engel, Monika Thommes, Peter Tonn

Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression
André Tadic, Dan Rujescu, Matthias J Müller, Ralf Kohnen, Hans H. Stassen, et al

Preliminary effects of pagoclone, a partial GABAA agonist, on neuropsychological performance
Angela F Caveney, Bruno Giordani, George M Haig

White versus gray matter function as seen on neuropsychological testing following bone marrow transplant for acute leukemia in childhood
Fiona S Anderson, Alicia S Kunin-Batson, Joanna L Perkins, K Scott Baker

Serum substance P levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics
Takahiko Nagamine

Effects of milnacipran on binge eating – a pilot study
Shun’ichi Noma, Teruhisa Uwatoko, Haruka Yamamoto, Takuji Hayashi

Normal pressure hydrocephalus co-existing with a second dementia disorder
Joseph Alisky

First true initial ictal SPECT in partial epilepsy verified by electroencephalography
Jesús Pastor, Luis Domínguez-Gadea, Rafael G Sola, Virgilio Hernando, María Luisa Meilán, et al

Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder
A Carlo Altamura, Jose M Goikolea

Erratum
Shapiro MA, Chang YL, Munson SK, et al.

  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio